|
US4741900A
(en)
|
1982-11-16 |
1988-05-03 |
Cytogen Corporation |
Antibody-metal ion complexes
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US5776427A
(en)
|
1992-03-05 |
1998-07-07 |
Board Of Regents, The University Of Texas System |
Methods for targeting the vasculature of solid tumors
|
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
|
WO1999061061A1
(fr)
|
1998-05-22 |
1999-12-02 |
Daiichi Pharmaceutical Co., Ltd. |
Composites medicamenteux
|
|
EP1243276A1
(en)
|
2001-03-23 |
2002-09-25 |
Franciscus Marinus Hendrikus De Groot |
Elongated and multiple spacers containing activatible prodrugs
|
|
US7375234B2
(en)
|
2002-05-30 |
2008-05-20 |
The Scripps Research Institute |
Copper-catalysed ligation of azides and acetylenes
|
|
AU2003293666A1
(en)
|
2002-11-11 |
2004-06-03 |
Basf Aktiengesellschaft |
Method for the production of 2-keto-l-gulonic acid-c4-c10 alkyl esters
|
|
WO2004043493A1
(en)
|
2002-11-14 |
2004-05-27 |
Syntarga B.V. |
Prodrugs built as multiple self-elimination-release spacers
|
|
ES2605443T3
(es)
|
2003-11-06 |
2017-03-14 |
Seattle Genetics, Inc. |
Conjugados de auristatina con anticuerpos anti-HER2 o anti-CD22 y su uso en terapia
|
|
CA2556752C
(en)
|
2004-02-23 |
2016-02-02 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
ES2398975T3
(es)
|
2004-03-01 |
2013-03-25 |
Spirogen Sàrl |
Derivados de 11-hidroxi-5H-pirrolo[2,1-c][1,4]benzodiazepin-5-ona como intermedios clave para la preparación de pirrolobenzodiazepinas sustituidas en C2
|
|
US7807619B2
(en)
|
2004-11-01 |
2010-10-05 |
The Regents Of The University Of California |
Compositions and methods for modification of biomolecules
|
|
ES2708763T3
(es)
|
2005-07-07 |
2019-04-11 |
Seattle Genetics Inc |
Compuestos de monometilvalina que tienen modificaciones de la cadena lateral de fenilalanina en el extremo C
|
|
WO2007008848A2
(en)
|
2005-07-07 |
2007-01-18 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus
|
|
EP2907525B1
(en)
|
2007-11-21 |
2018-05-16 |
University Of Georgia Research Foundation, Inc. |
Dibenzocyclooctene-compounds for bioorthogonal reactions
|
|
US20110301056A1
(en)
*
|
2008-12-12 |
2011-12-08 |
Oncotherapy Science, Inc. |
Nectin-4 for target genes of cancer therapy and diagnosis
|
|
FR2949469A1
(fr)
|
2009-08-25 |
2011-03-04 |
Sanofi Aventis |
Derives anticancereux, leur preparation et leur application en therapeutique
|
|
WO2011121453A2
(en)
|
2010-03-30 |
2011-10-06 |
Clavis Pharma Asa |
Methods and compositions for treating or ameliorating cancer using gemcitabine-5'-elaidate
|
|
MX368648B
(es)
|
2010-04-15 |
2019-10-09 |
Seattle Genetics Inc |
Pirrolobenzodiazepinas usadas para tratar enfermedades proliferativas.
|
|
ES2874306T3
(es)
|
2010-09-29 |
2021-11-04 |
Agensys Inc |
Conjugados de anticuerpos y fármacos (CAF) que se unen a las proteínas 191P4D12
|
|
SI2675480T1
(sl)
|
2011-02-15 |
2019-05-31 |
Immunogen, Inc. |
Metode priprave konjugatov
|
|
CA2858806A1
(en)
|
2011-12-23 |
2013-06-27 |
Innate Pharma |
Enzymatic conjugation of polypeptides
|
|
WO2013177481A1
(en)
|
2012-05-25 |
2013-11-28 |
Immunogen, Inc. |
Benzodiazepines and conjugates thereof
|
|
WO2014202773A1
(en)
|
2013-06-20 |
2014-12-24 |
Innate Pharma |
Enzymatic conjugation of polypeptides
|
|
PT3057585T
(pt)
|
2013-10-15 |
2020-10-21 |
Seagen Inc |
Fármaco-ligadores peguilados para farmacocinética melhorada de conjugados de fármaco-ligando
|
|
EP3733209A1
(en)
|
2014-10-03 |
2020-11-04 |
Synaffix B.V. |
Sulfamide linker, conjugates thereof, and methods of preparation
|
|
ES2885854T3
(es)
|
2014-10-14 |
2021-12-15 |
Polytherics Ltd |
Proceso para la conjugación de un péptido o proteína con un reactivo que comprende un grupo saliente que incluye una porción de PEG
|
|
US11274160B2
(en)
|
2017-03-02 |
2022-03-15 |
INSERM (Institut National de la Santé et de la Recherche Médicale |
Antibodies having specificity to Nectin-4 and uses thereof
|
|
TWI870338B
(zh)
*
|
2017-06-05 |
2025-01-21 |
美商艾澤西公司 |
粘附分子-4結合蛋白及其使用方法
|
|
EP3700577A1
(en)
|
2017-10-23 |
2020-09-02 |
Mablink Bioscience |
Ligand-drug-conjugate comprising a single molecular weight polysarcosine
|
|
CN113613679A
(zh)
|
2019-03-19 |
2021-11-05 |
保罗·谢勒学院 |
基于甘氨酸的接头的转谷氨酰胺酶缀合方法
|
|
AU2020364959B2
(en)
*
|
2019-10-07 |
2026-07-09 |
Centre National De La Recherche Scientifique - Cnrs - |
Antibodies having specificity for Nectin-4 and uses thereof
|
|
CN112646038B
(zh)
*
|
2019-10-11 |
2025-06-03 |
迈威(上海)生物科技股份有限公司 |
抗人Trop-2抗体及其应用
|
|
US20230025600A1
(en)
*
|
2019-11-25 |
2023-01-26 |
Agensys, Inc. |
Treatment of cancers with antibody drug conjugates (adc) that bind to 191p4d12 proteins
|
|
CN114845740B
(zh)
*
|
2020-01-31 |
2026-06-02 |
先天制药公司 |
癌症的治疗
|
|
CN113527486B
(zh)
*
|
2020-04-21 |
2025-12-02 |
迈威(上海)生物科技股份有限公司 |
一种抗Nectin-4的抗体及其应用
|
|
IL298903A
(en)
*
|
2020-06-18 |
2023-02-01 |
Bioatla Llc |
Antibodies against nectin-4 are conditionally active
|
|
US20230270871A1
(en)
*
|
2020-06-19 |
2023-08-31 |
Agensys, Inc. |
Markers for use in methods for treating cancers with antibody drug conjugates (adc)
|